MoneyWorks4Me

Lasa Supergenerics informs about press release

11 Apr 2022 Evaluate

Lasa Supergenerics has informed that it enclosed a copy of Press Release today titled ‘LASA SUPERGENERICS PAT AT 12.35 Cr up by Robust 362% as compared to Loss of 4.71 Cr in Q3FY22’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..